Kielflügel: J. B. Giusti, Lucca, ital. 1700, Kielflügel: Cristofori, 1703. 3 Manuale, Instrumentenabbildung, Sammlung der Pianofabrik J. C. Neupert, Internationale Ausstellung Musik im Leben der Völker, Frankfurt a. M., 1927

Signatur des Originals: S 36/F11366

Jean B. Cottereau, Brustbild, Profil

Signatur des Originals: S 36/G00021

Na 1 Nachlass Max Horkheimer, 634 - Aufsätze für die "Zeitschrift für Sozialforschung" und "Studies in Philosophy and Social Science" (p. IX 9.1-4-IX 10.1-7)

"Montaigne oder die Funktion der Skepsis" (GS 4, S.236-194), veröffentlicht in: Zeitschrift für Sozialforschung VII, 1938, S.1-54, englische Fassung des Aufsatzes, Typoskript, 69 Blatt; Exzerpte: Montaigne im Urteil der Nachwelt, Typoskripte, 29 Blatt; handschriftliche Stichworte zu Montaigne, 10 Blatt; 2 Zeitungsausschnitte; Leihscheine der Columbia University Library für Bücher über Montaigne; "Die Juden und Europa" (GS 4, S.308-331), veröffentlicht in: Studies in Philosophy and Social Science VIII, 1939, S. 115-137, a) Typoskript mit eigenhändigen Korrekturen, 31 Blatt, b) Typoskript mit eigenhändigen und handschriftlichen Korrekturen, 32 Blatt, c) Typoskript mit handschriftlichen Korrekturen, 27 Blatt, d) Typoskript mit handschriftlichen Korrekturen, Teilstücke, 16 Blatt, e) Typoskript mit eigenhändigen und handschriftlichen Korrekturen, 20 Blatt, f) überholte Formulierungen, Typoskript mit handschriftlichen Korrekturen, 10 Blatt; Bemerkungen zum Verhältnis von Liberalismus und Antisemitismus, a) Typoskript, 4 Blatt, b) Typoskript mit eigenhändigen Korrekturen, 9 Blatt (als Nachbemerkung zu: Ernst Engelberg: Exzerpt zu W. Frank und W. Grau), Typoskript, 1 Blatt; Exzerpte zu: Alvin Johnson, Honoré de Balzac, Guy de Maupassant, Paul Mahn, Marcel Proust, Anatole France, Marcel le Goff, Emile Zola, Typoskripte, 58 Blatt; Otto Kirchheimer: "Produktionswandel und Konzentrationstendenzen im Bankgewerbe", Typoskript, 2 Blatt; eigenhändige Adressennotiz, 1 Blatt; Otto Kirchheimer: "Reprivatisierungstendenzen des Faschismus", Typoskript mit eigenhändiger Ergänzung, 12 Blatt; Zeitungsausschnitte zur wirtschaftlichen Entwicklung, 1938, 8 Blatt;

Na 1 Nachlass Max Horkheimer, 643 - Korrekturen zur Neupublikation der Aufsätze Max Horkheimers aus der Zeitschrift für Sozialforschung und Vorwort zur Neupublikation 1968 (p. IX 23.1-20-IX 24.1-9)

1. Friedrich Pollock: Verzeichnis der Änderungen in den Essays nach der Bearbeitung durch Alfred Schmidt, 4 Blatt; 2. Derselbe: Eigenhändige Korrekturnotiz zum Manuskript Schmidt, 1 Blatt; 3. Derselbe: Eigenhändige Notiz über Verteilung von Korrekturen, 1 Blatt; 4. Derselbe: Ergänzungen zu den Korrekturen vom 15. und 20.03.1968. a) 8 Blatt b) 8 Blatt; 5. Korrekturen, 2 Blatt; 6. Friedrich Pollock [?]: Verzeichnis der Essays von Max Horkheimer und der Korrekturen. a) 8 Blatt b) Teilstücke, 2 Blatt; 7. Derselbe [?]: Verzeichnis der Korrekturen, 3 Blatt; 8. Derselbe: Eigenhändige Gesprächsnotiz, 1 Blatt; 9. Derselbe: Eigenhändige Gesprächsnotiz, 1 Blatt; 10. Derselbe: "Sprachregeln", eigenhändige Notiz, 1 Blatt; 11. Derselbe: "Bedenkliche Stellen", eigenhändiges Verzeichnis, 1 Blatt; 12. Derselbe: "Vorschlag für den Inhalt von Max Horkheimers Essays I", eigenhändiges Verzeichnis, 1 Blatt; 13. Derselbe: Eigenhändige Gesprächsnotiz Friedrich Pollocks - Max Horkheimers über Pro und Contra, Neuveröffentlichung, 1 Blatt; 14. S. Fischer Verlaf: Schätzung des Umfangs der Essys, 1 Blatt; 15. Friedrich Pollock: Verzeichnis der Essays von Max Horkheimer, 3 Blatt; 16. Handschriftliches Verzeichnis der Aufsätze, Reden und Schriften Max Horkheimers, 4 Blatt; 17. "Max Horkheimer Essays" Verzeichnis, 1 Blatt; 18. Schönbach, Peter: 1 Brief mit Unterschrift an Max Horkheimer Frankfurt, 11.09.1964, 7 Blatt; 19. Liste der Anmerkungen Frau Dr. Adornos zu den Aufsätzen Prof. Horkheimers in der Zeitschrift für Sozialforschung, 2 Blatt; 20. Adorno, Gretel: 4 Briefe mit Unterschrift an Max Horkheimer, Korrekturvorschläge Frankfurt am Main 1962-1963, 5 Blatt; Vowort zur Neupublikation 1968 der Aufsätze aus der Zeitschrift für Sozialforschung (GS 3, S. 14-19); 1964-1968; Veröffentlicht in: Max Horkheimer "Kritische Theorie", Frankfurt am Main 1968, Seite IX- IXV; 1. Entwürfe Juli- September 1968; 2. Kalb, Peter E.: 1 Brief an Max Horkheimer und Beilage, Frankfurt am Main, 02.08.1968, 2 Blatt; 3. Klappentext der Buchausgabe, Korrekturfahne mit handschriftlichen Korrekturen; 4. Adorno, Theodor W.: 1 Brief mit Unterschrift an Max Horkheimer, Frankfurt, 17.07.1968, 1 Blatt; 5. Horkheimer, Max: "Der neuste Angriff auf die Metaphysik". Sonderdruck der Zeitschrift für Sozialforschung VI, 1937, mit eigenhändigen Korrekturen; 6. Derselbe: "Autoritärer Staat" Teilstücke aus der Gedenkschrift für Walter Benjamin, 1942. Als Typoskript vervielfältigt, 21 Blatt; 7. "Zitate aus 'Autoritärer Staat' heute", 4 Blatt; 8. Schmidt, Alfred: "Zur Idee der kritischen Theorie" = Nachwort zur Buchausgabe. Typoskript mit handschriftlichen Korrekturen von Max Horkheimer, 38 Blatt; 9. N.N.: Ergänzungsvorschläge zu dem Nachwort von Dr. Schmidt, 3 Blatt;

Na 1 Nachlass Max Horkheimer, 690 - Materialien zu Forschungsprojekten über Antisemitismus u.a. (p. IX 157 - IX 163.1-9)

"Beitrag des Instituts für Sozialforschung zu dem Forschungsprojekt über Autorität" (3.1.1951). Typoskript, 5 Blatt; "Reactions to the Antisemitic Incidents in January 1960. A Pilot Study in Frankfurt am Main. Summary of Procedure and Results" (1960). Typoskript, 6 Blatt (= Alt.Sig. IX 234.13 a); "Proposal for International Study of Anti-Semitism" (1960):; 1. American Jewish Committee: Luncheon Meeting, May 25, 1960, Typoskript, 2 Blatt; 2. American Jewish Committee, Institute of Human Relations: "The JDA Agencies and Germany" (17.5.1960). Als Typoskript vervielfältigt, 32 Blatt; Exzerpte aus Werken über Antisemitismus, Literaturlisten (etwa 1933-46):; 1. Everett R. Clinchy, Typoskript, 1 Blatt; 2. Paul K. Hatt, Typoskript, 3 Blatt; 3. John Moffat Mecklin, Typoskript, 3 Blatt; 4. Conrad Henry Moehlman, Typoskript, 4 Blatt; 5. Maurice Samuel, Typoskript, 5 Blatt; 6. Milton Steinberg, Typoskript, 2 Blatt; 7. "General Literature on Antisemitism", Liste, Typoskript mit handschriftlichen Ergänzungen, 1 Blatt; 8. "Bibliography" zum Judentum, 15 Blatt; 9. Literaturliste, handschriftliche Notizen, 9 Blatt; 10. Literaturliste, eigenhändige Notizen von Max Horkheimer, 1 Blatt; 11. Literaturliste, 1 Blatt; 12. Zitate zum Judentum aus Zeitschriften, 1 Blatt; Memorandum zum Antisemitismus (1944-48):; 1. S. Andhil Fineberg: "Notes on 'A Mask for Privilege' by Carey McWilliams", als Typoskript vervielfältigt, 4 Blatt; Carey McWilliams: "Memorandum" (8.5.1948), Typoskript, 3 Blatt; Lawrence Bloomgarden und S.A. Fineberg: "In Reply to Carey McWilliams Memorandum of May 8th", Typoskript, 3 Blatt; 2. Rundbriefe der American Jewish Sociological Society, 1944, als Typoskript vervielfältigt, 4 Blatt; 3. Bericht über einen Vortrag von Wladimir Eliasberg über Antisemitismus, Typoskript, 1 Blatt; Abschriften und Übersetzungen aus Zeitungsartikeln über Antisemitismus (1939-43):; 1. "A Note on Anti-Semitism", aus: The New Statesman and Nation (13.3.1939), Typoskript, 7 Blatt; 2. Abschriften aus deutschen und englischen Zeitungen, 1939, Typoskript, 1 Blatt; 3. "A Homility of the Bishop of Cremona" (Übersetzung aus: Osservatore Romano) 1939. Typoskript, 18 Blatt; Veröffentlichungen über Antisemitismus, Vorurteil, Demagogie (1941-63):; 1. Earl Raab und Seymour M. Lipset: "Prejudice and Society", Freedom Pamphlet Anti-Defamation League of B'nai B'rith (New York 1963), 48 Seiten; 2. Committee on Education, Training and Research in Race Relations of the University of Chicago: Bulletin, Nr. 1, 30.6.1948, 55. Seiten; 3. Solomon Andhil Fineberg: "Checkmate for Rabble-Rousers. What to Do When the Demagogue Comes to Town", Sonderdruck aus Commentary, Vol. 2, 1946 und eine Broschüre, 20 Seiten; 4. Kurt Lewin: "A new Approach to Old Problems", aus: Congress Week, 19.1.1945, 2 Blatt; 5. Eric A. Johnston: "Intolerance", New York, 11.1.1945, Heft, 8 Blatt; 6. Philip Wylie: "Memorandum on Anti-Semitism", aus: American Mercury, Januar 1945, 5 Blatt; 7. S.I. Hayakawa: "Race and Words", aus: Common Sense, Juli 1943, 3 Blatt; 8. David Riesman: "The Politics of Persecution". Als Typoskript vervielfältigt, 21 Blatt; 9. James P. Gifford, Frank D. Schroth, Maximilian Moss, Edward A. Richards, Samuel J. Levinson, Thomas G. Grace: "Anti-Semitism. It's Causes and Cures", New York, 1941, 30 Seiten;

Zwei Reden : gehalten in der Synagoge zu Carlsruhe am 2 Mai d.J. bei dem Vorbereitungsgottesdienste für die Huldigungsfeier und am 9 Mai d.J. bei dem feierlichen Trauergottesdienste wegen Ablebens Seiner Königlichen Hoheit des höchstseligen Grossherzogs Leopold von Baden

von B. Willstätter

Non B-DNA structures and genomic instability associated with myotonic dystrophy type 2 (CCTG).(CAGG) repeats

There are many diseases associated with the expansion of DNA repeats in humans. Myotonic dystrophy type 2 is one of such diseases, characterized by expansions of a (CCTG)•(CAGG) repeat tract in intron 1 of zinc finger protein 9 (ZNF9) in chromosome 3q21.3. The DM2 repeat tract contains a flanking region 5' to the tract that consists of a polymorphic repetitive sequence (TG)14-25(TCTG)4-11(CCTG) n. The (CCTG)•(CAGG) repeat is typically 11-26 repeats in persons without the disease, but can expand up to 11,000 repeats in affected individuals, which is the largest expansion seen in DNA repeat diseases to date. This DNA tract remains one of the least characterized disease-associated DNA repeats, and mechanisms causing the repeat expansion in humans have yet to be elucidated. Alternative, non B-DNA structures formed by the expanded repeats are typical in DNA repeat expansion diseases. These sequences may promote instability of the repeat tracts. I determined that slipped strand structure formation occurs for (CCTG)•(CAGG) repeats at a length of 42 or more. In addition, Z-DNA structure forms in the flanking human sequence adjacent to the (CCTG)•(CAGG) repeat tract. I have also performed genetic assays in E. coli cells and results indicate that the (CCTG)•(CAGG) repeats are more similar to the highly unstable (CTG)•(CAG) repeat tracts seen in Huntington's disease and myotonic dystrophy type 1, than to those of the more stable (ATTCT)•(AGAAT) repeat tracts of spinocerebellar ataxia type 10. This instability, however, is RecA-independent in the (CCTG)•(CAGG) and (ATTCT)•(AGAAT) repeats, whereas the instability is RecA-dependent in the (CTG)•(CAG) repeats. Structural studies of the (CCTG)•(CAGG) repeat tract and the flanking sequence, as well as genetic selection assays may reveal the mechanisms responsible for the repeat instability in E. coli, and this may lead to a better understanding of the mechanisms contributing to the human disease state. ^

Process and outcome evaluation of the hepatitis B perinatal vaccination program in Houston, Texas, 1991--1993

A retrospective cohort study was designed to evaluate the compliance of vaccination dose schedules and vaccination effectiveness at 12 months of age among a total of 226 high-risk infants born to HBsAg-positive pregnant women who participated in the HBV Perinatal Vaccination Program in Houston, Texas, 1991-1993.^ The seroprevalence of HBsAg-positivity was 0.5% among pregnant women who attended prenatal clinics in Houston, Texas, 1991-1993. The Asian women had the highest seroprevalence rate (5.9%), followed by black (1.9%), white (0.7%), and Hispanic women (0.3%). The seroprevalence of HBsAg increased with age (p =.02); the highest seroprevalence rate found among the $>$40 group (5.4%), followed by the 20-40 age group, and the $<$20 age. A steady increase was observed in the number of infants, from 45 in 1991, to 103 in 1993. The majority of these infants were black (58.0%), followed by Hispanic (28.8%), Asian (8.4%), and white infants (4.0%). Significant increases were observed from 1991 to 1993 in the number of infants who initiated vaccination (86.7% to 98.1%, p =.02) and in those infants who were post-tested at 12 months of age (24.4% to 44.7%, p =.04). During the same period an increase was also observed in the number of infants who completed the vaccination dose schedules (62.2% to 72.8%, p =.37). The compliance rates were not statistically significant regarding gender, race or ethnicity, health service area, medical referral source, and residential geographic areas. About 56.0% of the reasons cited for non-compliance among the 144 infants who neither completed the vaccination dose schedules nor received the 12-month post-test were "moved," and "no response/not at home." A total of 82 infants completed the vaccination dose schedules and were post-tested at 12 months of age for anti-HBs-positivity, and 96.3% of these infants seroconverted. A race-specific statistically significant seroconversion difference was found among infants who received all vaccination doses and were post-tested at 12 months of age (100% for the black and the white, 96.3% for the Hispanic, and 80.0% for the Asians infants, p =.05).^ From a public health perspective, the HBV Perinatal Vaccination Program improved during its first three years (1991-1993). It was effective in preventing perinatal HBV infection in almost 97.0% of infants who were vaccinated and post-tested. To increase the efficiency and efficacy of the program, the following recommendations are proposed: (1) Increase the vaccination compliance rate by educating and improving the tracking, communication and coordination channels with those individuals involved in the process and by increasing staff resources. (2) Reduce the post-test vaccination non-compliance by post-testing infants simultaneously with third vaccination dose at 6 months of age, and only post-test those infants who are anti-HBs-negative at 9-12 months of age. (Abstract shortened by UMI.) ^

Prevalence and determinants of hepatitis B co-infection among a United States Veterans Administration cohort with hepatitis C

Background and aim. Hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infection is associated with increased risk of cirrhosis, decompensation, hepatocellular carcinoma, and death. Yet, there is sparse epidemiologic data on co-infection in the United States. Therefore, the aim of this study was to determine the prevalence and determinants of HBV co-infection in a large United States population of HCV patients. ^ Methods. The National Veterans Affairs HCV Clinical Case Registry was used to identify patients tested for HCV during 1997–2005. HCV exposure was defined as two positive HCV tests (antibody, RNA or genotype) or one positive test combined with an ICD-9 code for HCV. HCV infection was defined as only a positive HCV RNA or genotype. HBV exposure was defined as a positive test for hepatitis B core antibodies, hepatitis B surface antigen, HBV DNA, hepatitis Be antigen, or hepatitis Be antibody. HBV infection was defined as only a positive test for hepatitis B surface antigen, HBV DNA, or hepatitis Be antigen within one year before or after the HCV index date. The prevalence of exposure to HBV in patients with HCV exposure and the prevalence of HBV infection in patients with HCV infection were determined. Multivariable logistic regression was used to identify demographic and clinical determinants of co-infection. ^ Results. Among 168,239 patients with HCV exposure, 58,415 patients had HBV exposure for a prevalence of 34.7% (95% CI 34.5–35.0). Among 102,971 patients with HCV infection, 1,431 patients had HBV co-infection for a prevalence of 1.4% (95% CI 1.3–1.5). The independent determinants for an increased risk of HBV co-infection were male sex, positive HIV status, a history of hemophilia, sickle cell anemia or thalassemia, history of blood transfusion, cocaine and other drug use. Age >50 years and Hispanic ethnicity were associated with a decreased risk of HBV co-infection. ^ Conclusions. This is the largest cohort study in the United States on the prevalence of HBV co-infection. Among veterans with HCV, exposure to HBV is common (∼35%), but HBV co-infection is relatively low (1.4%). There is an increased risk of co-infection with younger age, male sex, HIV, and drug use, with decreased risk in Hispanics.^

Genetic variants within the Wnt/ B-catenin signaling pathway as indicators of bladder cancer clinical outcomes

The genetic factors that influence bladder cancer clinical outcomes are largely unknown. In this clinical outcomes study, I assessed genetic variations in the Wnt/β-catenin stem-cell pathway genes for association with recurrence and progression. A total of 230 SNPS in 40 genes from the Wnt/β-catenin pathway were genotyped in 419 histologically confirmed non-muscle invasive bladder cancer cases. Several significant associations were observed in the clinical outcomes analysis. Under the dominant model WNT8B: rs4919464 (HR: 1.55, 95% CI: 1.17-2.06, P=2.2x10-3) and WNT8B: rs3793771 (HR: 1.54, 95% CI: 1.09-1.62, P=4.6x10-3 ) were statistically significantly associated with an increase risk of recurrence while two other variants, APC2: rs11668593 (HR: 2.50, 95% CI: 1.43-4.35, P=1.2x10-3) and LRP5 : rs312778 (HR: 1.81, 95% CI: 1.23-2.65, P=2.7x10-3), were significantly associated with recurrence risk under the recessive model of inheritance. Four SNPs in the recessive model were associated with an increased risk of progression (AXIN2: rs1544427, LRP5: rs312778, AXIN1: rs370681, AXIN1: rs2301522). LRP5: rs312778 had the most significant increased risk of progression with a 2.68 (95% CI: 1.52-4.72, P=6.4x10-4)-fold increased risk. Stratification analysis based on treatment regimen (transurethral resection (TUR) and Bacillus Calmette-Guérin (BCG)) was also performed. Individuals with at least one variant in AXIN2: rs2007085 were found to have a 2.09 (95% CI: 1.24-3.52, P=5.4x10-3) -fold increased risk of recurrence in those that received TUR only, and no statistically significant effect was seen in those that received BCG. Individuals who received TUR with at least one variant in LEF1: rs10516550 were found to have a 2.26 (95% CI: 1.22-4.18, P=9.7x10-3)-fold increase risk of recurrence and no statistically significant effect was found in individuals who received BCG. Also, the recessive model of LRP6: rs2302684 in TUR only treatment was shown to have a 1.95 (95%CI: 1.18-3.21, P=8.8x10 -3)-fold increased risk of recurrence, and a suggested protective effect associated with a (HR: 0.83, 95% CI: 0.51-1.37, P=0.468) decreased risk of recurrence. Together, these findings implicate the Wnt/β-catenin stem-cell pathway as playing a role in bladder cancer clinical outcomes and have important implications for personalization of future treatment regimens. ^

Evaluation of memory B cells among perinatally HIV infected children from Houston Texas

Background: HIV associated B cell exhaustion is a notable characteristic of HIV viremic adults. However, it is not known if such alterations are present in perinatal HIV infected children, whose viral dynamics differs from those seen in adults. In the present study we perform an analysis of B cells subsets and measure antigen-specific memory B cells (MBC) in a pediatric HIV infected cohort. ^ Methods: Peripheral mononuclear cells (PBMC) of perinatal HIV infected individuals are characterized into naïve (CD21hi/CD27−), classic (CD27+), tissue like (CD21lo/CD27 −) and activated MBC (CD27+CD21− ) by FACS. A memory ELISPOT assay is used to detect antibody secreting cells. We measure total IgG and antibodies specific for influenza, HBV, mumps, measles, rubella and VZV. Memory was expressed as spot forming cells (SPC) /million of PBMC. Wilcoxon rank-sum was used to compare unpaired groups and linear regression analysis was used to determine predictors of B cell dysfunction ^ Results: 41 HIV perinatal infected children are included (51.2% females and 65.9% Black). Age at study is median (range) 8.78 years (4.39-11.57). At the time of testing they have a CD4% of 30.9 (23.2-39.4), a viral load (VL) of 1.95 log10 copies/ml (1.68-3.29) and a cumulative VL of 3.4 log10 copy × days (2.7-4.0). Ninety two percent of the children are on cARV for > 6 months. Overall, HIV+ children compared with controls have a significant lower number of IgG and antigen specific SFC. In addition, they have a lower proportion of classical MBC 12.9 (8.09-19.85) vs 29.4 (18.7-39.05); 0.01, but a significant higher proportion of tissue like memory MBC 6.01 (2.79-12.7) vs 0.99 (0.87-1.38); 0.003, compared with controls. Patients are parsed on VL (<400 and ≥ 400 copies/ml) with the objective to evaluate the effect of VL on B cell status. Patients with a VL ≥ 400 copies/ml have a significantly lower IgG, HBV, measles, rubella and VZV SPC compared with those with a VL < 400 copies/ml. There are no significant differences in B cell subpopulations between the groups. A moderate negative correlation was observed between the time of cARV initiation and the frequency of IgG memory B cells, suggesting that early initiation of cARV appears to lead to a better functionality of the IgG memory B cells (P=0.05). A statistically significant positive correlation was observed between the total number of IgG memory cells and the number of antigen-specific memory B cells/SPCs. Suggesting that the progressive recovery of the IgG memory B cell pull goes along with a progressive increase in the number of antigen-specific SPCs. ^ Conclusion: A pediatric cohort in overall good status with respect to HIV infection and on ART has defects in B cell function and numbers (reduced total and antigen specific MBC and increased tissue like and reduced classical MBC).^